-
CRISPR Therapeutics' (CRSP) "Market Outperform" Rating Reaffirmed at JMP Securities
来源: Buzz FX / 20 12月 2024 09:17:11 America/New_York
CRISPR Therapeutics' (CRSP) "Market Outperform" Rating Reaffirmed at JMP Securities Written by MarketBeat December 20, 2024 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "market outpe
Read more...